A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols05/01/2012 - 12/31/2015 (Co-Investigator)
PI:
Alik Farber, MDGrifols Inc.
A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm^2 to <= 36 cm^210/15/2013 - 08/30/2015 (Co-Investigator)
PI:
Alik Farber, MDHealthPoint Limited
A Non-Interventional Safety Study Providing 12 Months Follow-Up from First Exposure to HP802-247 in Subjects with Venous Leg Ulcer05/01/2012 - 04/30/2015 (Co-Investigator)
PI:
Alik Farber, MDHealthPoint Limited
A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers05/01/2012 - 04/30/2014 (Co-Investigator)
PI:
Alik Farber, MDHealthPoint Limited
A Phase 2, Randomized, Open-label Study to Evaluate the Effects of Different Intra-thrombus infusion Regimens of Plasmin (Human) Compared to Placebo02/01/2012 - 01/31/2013 (PI)
Aastrom Biosciences
PRESERVE
05/18/2016 - 08/31/2023 (PI)
New England Research Institute
BEST-CLI Trial: Randomized, Multicenter, Controlled Trial to Compare Best Endovascular vs Best Surgi08/25/2014 - 07/31/2023 (Multi-PI)
PI:
Jeffrey A. Kalish, MDNew England Medical Research Inst, Inc5U01HL107407-05
PRESERVE05/18/2016 - 05/31/2022 (PI)
New England Res Inst
The Angel Catheter Clinical Trial03/17/2015 - 04/17/2016 (PI)
Bio2Medical, Inc.